How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US

Currently, there is no import duty on drugs supplied by India to the US, but India…

Small drug makers face threat of closure if manufacturing norms are not met

The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI),…

Govt floats EOI for doing major Research & Development in pharma medtech sector | Mint

New Delhi: The government has sought expressions of interest (EoI) for research & development (R&D) projects…

India Drug, Auto Exporters See Limited Impact of US Tariffs

(Bloomberg) — Indian exporters don’t anticipate a major hit from US President Donald Trump’s latest threat…

drop the stick and change the law

In view of issues related to quality of generic drugs, it is not appropriate for DGHS…

Center invites online applications to open new Jan Aushadhi Kendras in 651 districts across India

New Delhi The Central Government on Thursday approved the proposal of Pharmaceuticals and Medical Devices Bureau…

Dr Reddy’s to acquire Slayback’s eyedrop rights

Pharma major Dr Reddy’s Laboratories has entered into a licensing agreement to acquire the rights to…

Mandaviya releases 9th edition of Indian Pharmacopoeia, praises domestic pharma

NEW DELHI: India is the world’s largest supplier of generic drugs and accounts for 20% of…

Cartelization process

Amanda Stark and Thomas G. Wolman, “Is there complicity in the penetration measure? Evidence from generic…